Cost effectiveness analysis comparing repetitive transcranial magnetic stimulation to antidepressant medications after a first treatment failure for major depressive disorder in newly diagnosed patients – A lifetime analysis

• Jeffrey Voigt ,

  Contributed equally to this work with: Jeffrey Voigt, Linda Carpenter, Andrew Leuchter

  Roles Writing – original draft

  * E-mail: meddevconsultant@aol.com

  Affiliation Medical Device Consultants of Ridgewood, LLC, Ridgewood, NJ, United States of America

  http://orcid.org/0000-0002-1755-8612

  ⨯
• Linda Carpenter ,

  Contributed equally to this work with: Jeffrey Voigt, Linda Carpenter, Andrew Leuchter

  Roles Writing – review & editing

  Affiliation Department of Psychiatry and Human Behavior, Brown Institute for Brain Science, Brown University, Providence, RI, United States of America

  ⨯
• Andrew Leuchter

  Contributed equally to this work with: Jeffrey Voigt, Linda Carpenter, Andrew Leuchter

  Roles Writing – review & editing

  Affiliation Neuromodulation Division, Semel Institute for Neuroscience and Human Behavior, University California Los Angeles, Los Angeles, CA, United States of America

  ⨯